01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Veterinary Drug Approval Process
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Chemical Class
08.1 Tetracyclines
08.2 Penicillins
08.3 Sulfonamides
08.4 Macrolides
08.5 Aminoglycosides
08.6 Cephalosporins
08.7 Others
09. Market Segmentation by Type of Animal
09.1 Aquatic Animals
09.2 Farm Animals
09.3 Companion Animals
10. Geographical Segmentation
10.1 Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2014-2019
10.2 Animal Antimicrobials and Antibiotics Market in Americas
10.2.1 Market Size and Forecast
10.3 Animal Antimicrobials and Antibiotics Market in EMEA
10.3.1 Market Size and Forecast
10.3.2 Animal Antimicrobials and Antibiotics Market in APAC Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Zoetis
18.2.2 Merck Animal Health
18.2.3 Merial
18.2.4 Elanco
18.2.5 Bayer
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Bayer
19.1.1 Key facts
19.1.2 Business Overview
19.1.3 Business segmentation by revenue 2014
19.1.4 Business segmentation by revenue 2013 and 2014
19.1.5 Geographical segmentation by revenue 2014
19.1.6 Business strategy
19.1.7 Recent developments
19.1.8 SWOT analysis
19.2 Elanco Animal Health
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Merck Animal Health
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Strategy
19.3.4 Recent Developments
19.3.5 SWOT Analysis
19.4 Merial
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Strategy
19.4.4 Recent Developments
19.4.5 SWOT Analysis
19.5 Zoetis
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2012 and 2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
20. Other Reports in this Series


List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Animal Antimicrobials and Antibiotics Market 2014-2019 ($ millions)
Exhibit 3: Global Animal Antimicrobials and Antibiotics Market by Chemical Class
Exhibit 4: Global Animal Antimicrobials and Antibiotics Market by Chemical Class 2014
Exhibit 5: Global Animal Antimicrobials and Antibiotics Market by Type of Animal
Exhibit 6: Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2014
Exhibit 7: Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2019
Exhibit 8: Animal Antimicrobials and Antibiotics Market in Americas 2014-2019 ($ millions)
Exhibit 9: Animal Antimicrobials and Antibiotics Market in EMEA 2014-2019 ($ millions)
Exhibit 10: Animal Antimicrobials and Antibiotics Market in APAC 2014-2019 ($ millions)
Exhibit 11: Revenue Comparison of the Major Vendors in the Global Animal Antimicrobials and Antibiotics market 2014 ($ millions)
Exhibit 12: Bayer: Business segmentation by revenue 2014
Exhibit 13: Bayer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 14: Bayer: Geographical segmentation by revenue 2014
Exhibit 15: Zoetis: Business Segmentation by Revenue 2013
Exhibit 16: Zoetis: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 17: Zoetis: Geographical Segmentation by Revenue 2013